
Mikrodosering
af Cibdol
Vi mailer dig kun om dette produkt — ingen markedsføring.
Cibdol Truffle Microdoses (FP) contain six pre-portioned 1 g doses of Psilocybe mexicana sclerotia, designed for the Fadiman Protocol — the most conservative microdosing schedule available. One day on, two days off. This is the product we hand to anyone who walks into Azarius and says "I want to try microdosing but I've never touched psilocybin before." The FP is built for that exact moment: low intensity, maximum rest days, and the mildest truffle species in the Cibdol line.
Psilocybe mexicana is the gentlest of the three species Cibdol uses across their microdosing range. Where P. tampanensis (OP) leans toward analytical sharpness and P. galindoi (SP) targets creative flow, mexicana's character profile centres on relaxation, emotional integration, and inner calm. At 1 g fresh — roughly 0.3 g dry, containing approximately 1-2 mg of psilocybin — you are well below the perceptual threshold. No visuals, no body load, no impairment. What users consistently report is a quiet reduction in background stress, a greater ease in processing emotions, and a gentler baseline mood across the dosing cycle.
The "FP" stands for Fadiman Protocol, named after psychologist James Fadiman, who popularised the 1-on-2-off schedule in the early 2010s. Fadiman's reasoning was straightforward: dose on Day 1, observe aftereffects on Day 2, return to baseline on Day 3, then repeat. The two rest days make it the most forgiving protocol — if you're sensitive to psilocybin, you have ample time to recalibrate. We've sold all three Cibdol protocols since launch, and the FP outsells the other two among first-time buyers by a clear margin. People start here, figure out how their body responds, then decide whether to move to the SP or OP later.
Each dose is 1 g of fresh Psilocybe mexicana sclerotia. Fresh truffles contain 65-70% water, so 1 g fresh yields roughly 0.3 g dry weight — equivalent to approximately 1-2 mg of psilocybin. That is sub-perceptual: no visuals, no altered state, no impairment.
Microdose (this product): 1 g fresh / ~0.3 g dry / ~1-2 mg psilocybin. No perceptual effects. Emotional and mood support only.
If you've done a full cycle on the FP and want something with more active days per week, try the Stamets Protocol (SP) — it uses a medium-potency species on a 4-5-on, 2-3-off schedule.
| Species | Psilocybe mexicana (sclerotia) |
| Active compounds | Psilocybin (prodrug), psilocin (active metabolite, serotonergic 5-HT2A receptor agonist), baeocystine (minor tryptamine alkaloid) |
| Dose per portion | 1 g fresh sclerotia (~0.3 g dry, ~1-2 mg psilocybin) |
| Portions per pack | 6 |
| Protocol | Fadiman Protocol — 1 day on, 2 days off |
| Active days per week | 2-3 |
| Character | Relaxation, emotional integration, inner calm, stability |
| Perceptual level | Sub-perceptual — no visuals, no altered state |
| Brand | Cibdol |
| Storage | Refrigerate at 2-8 °C. Perishable — use within the shelf date on packaging. |
Ready for more? Pair with the other Cibdol protocols
Once you've completed a full Fadiman cycle and know how your body responds, consider stepping up. The Truffle Microdoses (SP) use medium-potency P. galindoi on a 4-5-day dosing rhythm — built for creative flow and brainstorming. The Truffle Microdoses (OP) use the strongest species (P. tampanensis) on an alternating-day schedule for analytical focus and sustained cognitive sharpness.
Psilocybe mexicana has the longest human history of any psilocybin species. Mesoamerican cultures — particularly the Mazatec people of Oaxaca, Mexico — used this species in ceremonial and healing contexts for centuries before Western science became aware of it. In 1958, Swiss chemist Albert Hofmann (the same person who synthesised LSD) isolated psilocybin and psilocin from Psilocybe mexicana for the first time, making it the species that introduced these compounds to modern pharmacology.
The Fadiman Protocol itself comes from James Fadiman, a psychologist and researcher who has studied psychedelics since the 1960s. Fadiman published his microdosing protocol in The Psychedelic Explorer's Guide (2011), based on systematic self-reports collected from hundreds of volunteers. His 1-on-2-off schedule was deliberately conservative — designed to give people enough rest days to notice what changed, and to prevent the tolerance buildup that more frequent dosing can cause. It remains the most widely recommended starting protocol for first-time microdosers, and the pairing with P. mexicana — the mildest available species — makes biological sense: gentle compound, gentle schedule.
At a sub-perceptual 1 g fresh dose, Psilocybe mexicana does not produce hallucinations, uplifting, or perceptual distortion. The FP's character profile sits at the opposite end of the spectrum from the OP's cognitive sharpness — this is about emotional processing, not mental performance.
Psilocybin and psilocin bind to serotonin 5-HT2A receptors, primarily in the prefrontal cortex. At microdose levels, this serotonergic activity modulates the default-mode network — the brain circuitry associated with self-referential thinking, rumination, and habitual emotional patterns. A 2022 study in Neuropsychopharmacology showed that psilocybin promotes dendritic spine growth in cortical neurons, suggesting a structural basis for the increased mental flexibility and emotional openness users describe. These effects are cumulative — they build over weeks of consistent dosing, not after a single dose.
Based on Cibdol's character framework and customer feedback we've gathered at Azarius:
| Effect | Rating |
|---|---|
| Inner calm | 4/5 |
| Emotional stability | 4/5 |
| Mental flexibility | 3/5 |
| Mood lift | 3/5 |
| Creative flow | 2/5 |
| Analytical focus | 2/5 |
The pattern is the inverse of the OP: the FP leans toward emotion rather than cognition. The honest trade-off is that if you need creative output or analytical performance, this isn't the right protocol — you'll want the SP or OP for that. The FP deliberately sacrifices cognitive edge for emotional balance. If you're dealing with stress, processing a difficult period, or simply want a gentler baseline mood, that trade-off works in your favour.
The Global Drug Survey, the world's largest annual drug use survey, consistently reports that psilocybin ranks among the safest psychoactive substances in terms of emergency medical treatment — even at full doses. At microdose levels, the safety margin is significantly wider.
Psilocybe mexicana sclerotia are the mildest-tasting of the three Cibdol species. The flavour is earthy and nutty — similar to a raw cashew with a faint sour undertone — without the sharper tang of tampanensis or the slightly fermented edge of galindoi. The texture is softer and more crumbly than the other two species, which makes the 1 g dose quick to chew — about 10 seconds, then swallow. If you're sensitive to earthy flavours, wash it down with orange juice. At this dose size, masking the taste is barely necessary — it's a mouthful, not a meal.
Psilocybin has a strong safety profile relative to other psychoactive substances. It is not physically addictive, carries very low physiological toxicity, and produces rapid tolerance that discourages compulsive redosing. The Global Drug Survey has ranked psilocybin-containing products among the least likely to require emergency medical attention across all categories surveyed.
Contraindications: Do not use psilocybin microdoses if you have a personal or family history of psychosis or schizophrenia. Psilocybin acts on serotonin pathways, and combining it with SSRIs (selective serotonin reuptake inhibitors) or MAO inhibitors can cause unpredictable interactions. If you are on any serotonergic medication, speak with your prescribing doctor before starting a microdosing protocol.
This is not a recreational product. At 1 g fresh, you will not feel "high." There are no visuals, no altered perception, no impairment. If for any reason you feel uneasy after a dose, remember: the effects of psilocybin are temporary. They pass within hours, and at microdose levels, within 1-2 hours at most. Stay hydrated, stay comfortable, and wait it out.
Do not combine with alcohol or other substances. Do not drive or operate heavy machinery until you know how your body responds to the protocol — though at this dose level, impairment is not expected.
| Truffle Microdoses (FP) | Truffle Microdoses (SP) | Truffle Microdoses (OP) | |
|---|---|---|---|
| Species | Psilocybe mexicana | Psilocybe galindoi | Psilocybe tampanensis |
| Potency | Mild (gentlest) | Medium | Medium-strong (strongest) |
| Protocol | Fadiman Protocol | Stamets Protocol | One-Day Protocol |
| Schedule | 1 day on, 2 days off | 4-5 days on, 2-3 days off | 1 day on, 1 day off |
| Active days/week | 2-3 | 4-5 | 3-4 |
| Character | Relaxation, emotional integration, inner calm | Creative flow, divergent thinking, perspective shifts | Analytical focus, daily sharpness, work performance |
| Good for | First-time microdosers, people seeking calm and emotional balance, those processing stress or transitions | Designers, writers, musicians, anyone in creative problem-solving roles | Programmers, researchers, analysts, students with demanding cognitive workloads |
| Dose per portion | 1 g fresh | 1 g fresh | 1 g fresh |
| Portions | 6 | 6 | 6 |
Psilocybe mexicana sclerotia contain three principal tryptamine alkaloids:
| Compound | Role | Typical concentration (dry weight) |
|---|---|---|
| Psilocybin | Prodrug — converted to psilocin in the liver via dephosphorylation | 0.2-0.5% |
| Psilocin | Active metabolite — binds serotonin 5-HT2A receptors, responsible for cognitive and emotional effects | 0.01-0.1% |
| Baeocystine | Minor tryptamine alkaloid — similar structure to psilocybin, pharmacological contribution not fully characterised | Trace amounts |
Fresh sclerotia contain 65-70% water. A 1 g fresh dose yields approximately 0.3 g dry material, containing roughly 1-2 mg of psilocybin. At this level, psilocin concentrations in the brain remain below the threshold for perceptual changes, but are sufficient to engage 5-HT2A receptor-mediated neuroplasticity — including the dendritic spine growth documented in the 2022 Neuropsychopharmacology study and the default-mode network modulation observed in functional imaging research. The lower psilocybin concentration in P. mexicana compared to P. tampanensis (0.2-0.5% vs 0.3-0.7%) is what makes it the mildest option — less active compound per gram means a gentler experience at the same 1 g dose.
Norbaeocystine is present in trace amounts. Its pharmacological role remains under investigation, but like baeocystine it belongs to the tryptamine family and may contribute to the overall serotonergic profile of the sclerotia. The presence of multiple alkaloids — even in trace quantities — suggests a more varied interaction with serotonin receptors than purified psilocybin alone would produce.
The Fadiman Protocol is a microdosing schedule created by psychologist James Fadiman. You take one dose on Day 1, observe aftereffects on Day 2 (no dose), rest on Day 3, then repeat. It's the most conservative standard protocol — 2-3 active days per week — and the most recommended starting point for first-time microdosers.
Each pack contains 6 individually portioned 1 g doses of fresh Psilocybe mexicana sclerotia (also called philosopher's stones or magic truffles). The active compounds are psilocybin, psilocin, and baeocystine — tryptamine alkaloids that act on serotonin receptors. At 1 g fresh, the dose is sub-perceptual.
No. One gram of fresh sclerotia contains approximately 1-2 mg of psilocybin — well below the perceptual threshold. You won't experience visuals, uplifting, or impairment. The effects are subtle and cumulative: reduced background stress, easier emotional processing, and a calmer baseline mood over weeks of consistent use.
Two reasons: the mildest species and the most rest days. Psilocybe mexicana has the lowest psilocybin concentration of the three Cibdol species, and the Fadiman schedule gives you 2 off-days for every dose day. That combination means less exposure, more time to observe how your body responds, and the lowest chance of any unwanted effects.
Roughly 18 days. With 6 doses and a 3-day cycle (1 on, 2 off), each dose covers 3 calendar days. That's nearly three weeks from one pack — longer than the OP (12 days) or SP (8-9 days) on their respective schedules.
FP uses the mildest species (P. mexicana) on the most conservative schedule for emotional calm. SP uses mid-potency P. galindoi on a 4-5-day rhythm for creative flow. OP uses the strongest species (P. tampanensis) on alternating days for analytical focus. Choose based on what you need: calm, creativity, or cognition.
Psilocybin and SSRIs both act on serotonin pathways. Most SSRI users report reduced or absent microdosing effects. Do not adjust your medication to microdose — speak with your prescribing doctor about any changes to your routine.
Refrigerate at 2-8 °C. Keep the packaging sealed between uses. Fresh sclerotia are perishable — do not freeze, as this damages cell structure and degrades the active compounds. Use before the expiry date on the pack.
Psilocybin has a strong safety profile: it is not addictive, carries very low physiological toxicity, and builds rapid tolerance that discourages overuse. The Global Drug Survey ranks psilocybin among the least likely substances to require emergency medical treatment. The main contraindications are a history of psychosis and concurrent use of serotonergic medications.
Last updated: April 2026


Denne produktbeskrivelse er udarbejdet med AI-assistance og gennemgået af Adam Parsons, Senior Writer & Reviewer. Redaktionelt tilsyn af Joshua Askew.
Medicinsk forbehold. Dette indhold er udelukkende til orientering og udgør ikke medicinsk rådgivning. Konsulter en kvalificeret sundhedsperson, før du bruger et hvilket som helst stof.